Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 30  •  10:08AM ET
10.64
Dollar change
+0.01
Percentage change
0.09
%
Index
-
P/E
36.64
EPS (ttm)
0.29
Insider Own
21.26%
Shs Outstand
17.25M
Perf Week
-0.47%
Market Cap
233.10M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
17.25M
Perf Month
0.57%
Enterprise Value
233.27M
PEG
-
EPS next Q
-
Inst Own
77.89%
Perf Quarter
1.04%
Income
6.36M
P/S
-
EPS this Y
-
Inst Trans
-
Perf Half Y
2.26%
Sales
0.00M
P/B
1.33
EPS next Y
-
ROA
3.57%
Perf YTD
1.43%
Book/sh
7.99
P/C
7769.97
EPS next 5Y
-
ROE
3.70%
52W High
10.69 -0.47%
Perf Year
4.42%
Cash/sh
0.00
P/FCF
-
EPS past 3/5Y
- -
ROIC
3.63%
52W Low
10.15 4.83%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
- -
Gross Margin
-
Volatility
0.15% 0.12%
Perf 5Y
-
Dividend TTM
-
EV/Sales
-
EPS Y/Y TTM
-
Oper. Margin
-
ATR (14)
0.02
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.07
Sales Y/Y TTM
-
Profit Margin
-
RSI (14)
63.15
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.07
EPS Q/Q
18300.00%
SMA20
0.39%
Beta
-0.00
Target Price
-
Payout
0.00%
Debt/Eq
0.00
Sales Q/Q
-
SMA50
0.80%
Rel Volume
0.00
Prev Close
10.63
Employees
2
LT Debt/Eq
0.00
Earnings
-
SMA200
3.07%
Avg Volume
8.19K
Price
10.64
IPO
Feb 13, 2025
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
1
Change
0.09%
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.